Chemical Compound Review:
Securopen (2R,5R,6S)-3,3-dimethyl-7- oxo-6-[[2-[(2...
Synonyms:
Azlocilina, azlocillin, Azlin, Azlocilline, Azlocillinum, ...
- In-vitro activity of azlocillin against Pseudomonas. Chattopadhyay, B., Hall, I. Lancet (1979)
- Ciprofloxacin versus tobramycin plus azlocillin in pulmonary exacerbations in adult patients with cystic fibrosis. Bosso, J.A., Black, P.G., Matsen, J.M. Am. J. Med. (1987)
- Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats. Johnson, D.E., Thompson, B. Am. J. Med. (1986)
- In vitro activity and in vivo evaluation of ticarcillin plus clavulanic acid against aerobic and anaerobic bacteria. Bansal, M.B., Chuah, S.K., Thadepalli, H. Am. J. Med. (1985)
- Quality control and interpretive criteria for the azlocillin disk diffusion susceptibility test. Fass, R.J. Antimicrob. Agents Chemother. (1982)
- Concentration of azlocillin in human chondral tissue. Schönfeld, W., Knöller, J., Bremm, K.D., Meier, H., König, W. Zentralblatt für Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology. (1988)
- Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods. Moody, J.A., Gerding, D.N., Peterson, L.R. Am. J. Med. (1987)
- Kinetic interactions between azlocillin, cefotaxime, and cefotaxime metabolites in normal and impaired renal function. Kampf, D., Borner, K., Möller, M., Kessel, M. Clin. Pharmacol. Ther. (1984)
- Interaction of zwitterionic penicillins with the OmpF channel facilitates their translocation. Danelon, C., Nestorovich, E.M., Winterhalter, M., Ceccarelli, M., Bezrukov, S.M. Biophys. J. (2006)
- Structure-activity relationships of different beta-lactam antibiotics against a soluble form of Enterococcus faecium PBP5, a type II bacterial transpeptidase. Hujer, A.M., Kania, M., Gerken, T., Anderson, V.E., Buynak, J.D., Ge, X., Caspers, P., Page, M.G., Rice, L.B., Bonomo, R.A. Antimicrob. Agents Chemother. (2005)
- Time-survival studies for quantifying effects of azlocillin and tobramycin on Pseudomonas aeruginosa. McFarland, M.M., Scott, E.M., Li Wan Po, A. Antimicrob. Agents Chemother. (1994)
- In vitro models for the study of combination antibiotic therapy in neutropenic patients. Zinner, S.H., Dudley, M., Blaser, J. Am. J. Med. (1986)
- Binding of monobactams to penicillin-binding proteins of Escherichia coli and Staphylococcus aureus: relation to antibacterial activity. Georgopapadakou, N.H., Smith, S.A., Cimarusti, C.M., Sykes, R.B. Antimicrob. Agents Chemother. (1983)
- Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin, and ticarcillin. Phaneuf, D., Neu, H.C. Antimicrob. Agents Chemother. (1979)
- In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolates of Pseudomonas aeruginosa. Bustamante, C.I., Wharton, R.C., Wade, J.C. Antimicrob. Agents Chemother. (1990)
- Effect of aztreonam in combination with azlocillin or piperacillin on Pseudomonas aeruginosa. Wu, D.H., Baltch, A.L., Smith, R.P., Conley, P.E. Antimicrob. Agents Chemother. (1984)
- Pharmacokinetics of azlocillin in subjects with normal and impaired renal function. Leroy, A., Humbert, G., Godin, M., Fillastre, J.P. Antimicrob. Agents Chemother. (1980)
- Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo. McLaughlin, F.J., Matthews, W.J., Strieder, D.J., Sullivan, B., Taneja, A., Murphy, P., Goldmann, D.A. J. Infect. Dis. (1983)
- Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa. White, A.R., Comber, K.R., Sutherland, R. Antimicrob. Agents Chemother. (1980)
- Prolonged bleeding time during azlocillin therapy. Dijkmans, B.A., Van Der Meer, J.W., Boekhout-Mussert, M.J., Zaal-De Jong, M., Mattie, H. J. Antimicrob. Chemother. (1980)
- Materno-fetal transfer of azlocillin. Kafetzis, D.A., Brater, D.C., Fanourgakis, J.E. J. Antimicrob. Chemother. (1983)
- Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Scribner, R.K., Marks, M.I., Weber, A.H., Tarpay, M.M., Welch, D.F. Antimicrob. Agents Chemother. (1982)
- The tolerance and safety of azlocillin. Parry, M.F. J. Antimicrob. Chemother. (1983)
- Comparative pharmacokinetics of azlocillin and piperacillin in normal adults. Colaizzi, P.A., Polk, R.E., Poynor, W.J., Raffalovich, A.C., Cefali, E.A., Beightol, L.A. Antimicrob. Agents Chemother. (1986)
- Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions. Chalkley, L.J., Koornhof, H.J. Antimicrob. Agents Chemother. (1985)
- A comparison of azlocillin and gentamicin in the treatment of serious infections caused by Pseudomonas aeruginosa. Gonzalez, M.A. J. Antimicrob. Chemother. (1983)
- Comparative in-vitro activity of ciprofloxacin against non-fermenters. Husson, M.O., Izard, D., Bouillet, L., Leclerc, H. J. Antimicrob. Chemother. (1985)
- Improved procedure for the determination of the ureidopenicillins azlocillin and mezlocillin plasma by high-performance liquid chromatography. Hildebrandt, R., Gundert-Remy, U. J. Chromatogr. (1982)
- Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa. Wu, Y.L., Scott, E.M., Po, A.L., Tariq, V.N. J. Antimicrob. Chemother. (1999)
- Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis. McLaughlin, F.J., Matthews, W.J., Strieder, D.J., Sullivan, B., Goldmann, D.A. J. Antimicrob. Chemother. (1983)
- Comparative study of the binding of acylureidopenicillins and carbenicillin to human serum proteins. Rosenkranz, H., Förster, D. Infection (1979)
- Relevance of in vitro antibacterial activities and pharmacokinetic properties of antipseudomonal beta-lactam antibiotics to their therapeutic effects on urinary tract infection caused by Pseudomonas aeruginosa P 9 in mice. Nakao, M., Nishi, T., Kondo, M., Fugono, T., Imada, A., Tsuchiya, K. J. Antibiot. (1984)
- Intravenous azlocillin kinetics in patients on long-term hemodialysis. Aletta, J.M., Francke, E.F., Neu, H.C. Clin. Pharmacol. Ther. (1980)
- High-pressure liquid chromatographic quantitation of azlocillin. Weber, A., Opheim, K.E., Wong, K., Smith, A.L. Antimicrob. Agents Chemother. (1983)
- Pharmacokinetic comparison of 5 g of azlocillin every 8 h and 4 g every 6 h in healthy volunteers. Lander, R.D., Henderson, R.P., Pyszczynski, D.R. Antimicrob. Agents Chemother. (1989)
- Effect of azlocillin on uric acid levels in serum. Ernst, J.A., Sy, E.R. Antimicrob. Agents Chemother. (1983)